CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Onyx Therapeutics, Inc. v. Sagent Pharmaceuticals, Inc.

1:16-cv-01000

Overview

Case Number 1:16-cv-01000
Filing Date 2016-10-26
Status Terminated
Termination Date 2019-05-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Sagent Pharmaceuticals, Inc. Operating Company

Represented By

1 Attorneys Listed

Kenneth Laurence Dorsney

Morris James LLP

Tel: +1 (302) 888-6855
Fax: +1 (302) 571-1750

500 Delaware Avenue, Suite 1500, P.O. Box 2306

Plaintiff

Onyx Therapeutics, Inc. Operating Company

Represented By

6 Attorneys Listed

Wendy A. Whiteford

Email: wendy@amgen.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Margaret A. O'Boyle

Email: moboyle@omm.com

Lisa Barons Pensabene

O'Melveny & Myers LLP

Tel: +1 (212) 326-2077
Fax: +1 (212) 326-2061

7 Times Square, Times Square Tower, New York, NY 10036

Brian Kao

UNDELIVERABLE 6/11/2020

UNDELIVERABLE 6/11/2020

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7417042
Compounds for enzyme inhibition
Filed: 2005-08-08
Issued: 2008-08-26
Active (0.8 yrs remaining) +765d PTA
Expires: 2027-09-12
US7232818
Compounds for enzyme inhibition
Filed: 2005-04-14
Issued: 2007-06-19
Expired (Term Ended)
Expires: 2025-04-14
US7491704
Compounds for enzyme inhibition
Filed: 2007-04-11
Issued: 2009-02-17
Expiring Soon (142 days)
Expires: 2027-04-11
US7737112
Composition for enzyme inhibition
Filed: 2005-12-07
Issued: 2010-06-15
Active (1.1 yrs remaining) +742d PTA
Expires: 2027-12-19
US8129346
Compounds for enzyme inhibition
Filed: 2005-04-14
Issued: 2012-03-06
Expiring Soon (35 days) +620d PTA
Expires: 2026-12-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+765 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 3 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for purposes of discovery and all paper...
Entry #19 • 2017-04-18 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to March 29, 2017 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Ent...
Entry #17 • 2017-03-22 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 7 STIPULATION TO EXTEND TIME for Defendant Sagent Pharmaceuticals, Inc. to answer, move or otherwise respond to the Complaint to January 17, 2017...
Entry #β€” • 2016-11-09
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant Sagent Pharmaceuticals, Inc. to answer, move or otherwise respond to the Complaint to January 17, 2017 - filed by Sagen...
Entry #7 • 2016-11-03 Document →

Docket Entries

(42 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Sagent Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-202185.) - filed by Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A - I, # 2 Civil Cover Sheet)(lmm) (Entered: 10/27/2016)

Entry #1 • 2016-10-26
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Sagent Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-202185.) - filed by Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A - I, # 2 Civil Cover Sheet)(lmm) (Entered: 10/27/2016)

Entry #1 • 2016-10-26
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Sagent Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-202185.) - filed by Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A - I, # 2 Civil Cover Sheet)(lmm) (Entered: 10/27/2016)

Entry #1 • 2016-10-26
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) (Entered: 10/27/2016)

Entry #2 • 2016-10-26
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September, 13, 2006. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 1/20/2020. (lmm) (Entered: 10/27/2016)

Entry #3 • 2016-10-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc